The Europe Chaga Mushroom Market would witness market growth of 6.4% CAGR during the forecast period (2022-2028).
Chaga mushrooms have been shown to improve absorption and help fight other illnesses, including diabetes and cholesterol. The chaga mushroom has long been used for its potential benefits in maintaining a healthy stomach-related system. Almost 200 distinct bioactive metabolites have been identified via scientific analysis. Several of them may promote human health, including many polysaccharides, such as beta-glucans, melanin, triterpenes, derivatives of benzoic acid, ergonovine and ergonovine peroxide, sesquiterpene, and hispidin.
Out of them the polysaccharides in chaga are the substances that are the most active. Large molecules known as polysaccharides are created from several simple sugars (monosaccharides). The beta-D-glucans are the most significant polysaccharides identified in chaga. Chaga and other functional mushrooms contain beta-glucans, with unique possibilities for creating novel therapeutics. Because of their many health advantages, including their immunomodulatory, hepatoprotective, and antioxidative actions, beta-glucans have attracted a lot of interest lately.
In 2017–18, the UK's health budget was £124.7 billion, an increase of 1.8% over the year before. The increased incidence of chronic illnesses was the primary cause of the high domestic demand for pharmaceutical items. Breast, prostate, and colorectal cancers account for more than 50% of all malignancies in the UK, where cancer incidence is still rising. During the last 20 years, the number of diabetes diagnoses has more than doubled. By 2035, it is anticipated that the number of obese persons in the UK will double. With £146 million in state funding committed through 2023 for advanced treatment, medication, and vaccine research and manufacture, R&D is still seeing substantial growth in the UK. The regional market would expand as a result of this factor.
The Germany market dominated the Europe Chaga Mushroom Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $92.9 Million by 2028. The UK market is anticipated to grow at a CAGR of 5.6% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 7.2% during (2022 - 2028).
Based on Nature, the market is segmented into Conventional and Organic. Based on Form, the market is segmented into Powder and Liquid. Based on End Use, the market is segmented into Food & Beverage Industry, Dietary Supplements, Pharmaceuticals and Cosmetics & Personal Care. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Chaga Mushroom Market is Projected to reach USD 1.1 Billion by 2028, at a CAGR of 6.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Naturalin Bio-Resources Co., Ltd, Xiamen Boten Biological Technology Co., Ltd., Om Mushroom Superfood, Annanda Chaga Mushrooms, Touchwood Mushrooms, Hangzhou Muhua Bio-Tech Co., Ltd, White Mountain Mushrooms, LLC, Baikal Herbs Ltd and Sayan Health, Inc.
By Nature
By Form
By End Use
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
